Post-Operative Digital Assessment

NY Presbyterian.png

Fitango Health and New York Presbyterian's Urology Oncology department are partnered in an initiative to improve post-discharge care in the patient's home and reduce post-operative hospital readmissions. 

Fitango Health's technology allows patient's to report electronically on recovery from home and supports remote recovery monitoring with alerts and notifications to the physician depending on assessment responses.

  • Study Title: "Efficacy of post-operative electronic questionnaires and virtual video visits following urologic and general surgery in decreasing postoperative readmissions."

  • Study Design: Non-randomized, open-label study where patients receive electronic questionnaires via the Fitango Health mobile app every other day and video calls every week or when prompted by one of the questionnaire answers, for a two week period post-discharge

  • Principal Investigator: Douglas S. Scherr, M.D.

  • Sample Size: N=300

  • Study Population: Patients undergoing major urological surgery with Dr. Scherr and spending at least one night in the hospital

  • Study Duration: Intervention is 2 weeks long and patients are tracked for a total of 90 days post-discharge to assess readmission rates

Contact Us

Fitango Digital Health (DAB), Ltd. (Israel)
Pinkas 66, Suite 161
Tel Aviv, 6215719
+972 (0)3 972-4555
Fitango Health, Inc. (USA) 119 W 57th St Suite 615
New York, NY 10019
+1 212-956-0555

© 2021  Fitango Health, Inc.